Table 1 Studies and datasets used in the analysis.
From: Protective effect of uridine on atrial fibrillation: a Mendelian randomisation study
Data source | Phenotype | Sample size | Cases | Population | Adjustment |
|---|---|---|---|---|---|
Metabolomics GWAS server | uridine | 7824 | – | European | Age, gender, and body mass index |
GWAS meta-analysis (Nielsen et al.) | AF | 1,030,836 | 60,620 | European | Age, sex, and principal components 1–4 |
AF HRC | AF | 588,190 | 65,446 | 91% European | Age, sex, and principal components 1–10 |
FinnGen | AF | 164,491 | 28,670 | European | Age, sex, and up to 20 genetic principal components |
